Northern Tiger Resources Obtains Final Assay Results from 3Ace Property
Northern Tiger Resources has received the assay results of the final nine holes drilled during the 2011 program at the 3Ace property, Southeast Yukon. The Main Zone will be expanded along strike to an additional 50 m towards the northern part in view of the present assay results. These results show the continuity of the strong down-dip zone.
The company has encountered 1.18 g/t gold over 31.7 m in hole 3A-11-19, 17.72 g/t over 2.0 m and 2.58 g/t gold over 53.0 m in hole 3A-11-33, 70.11 g/t gold over 1.1 m and 4.37 g/t gold over 10.0 m in hole 3A-11-34.
The hole 3A-11-35 is a 50 m step out hole located in the Main zone towards the northern part of the hole 3A-11-14. Two mineralized gold zones have been intercepted in the hole 3A-11-35. The company has yielded 4.95 g/t gold over 7.2 m in the hole 3A-11-14. The steeper holes 3A-11-19, 3A-11-31, and 3A-11-33 were drilled from the current pads. The step-back hole 3A-11-34 has been drilled to 25 m. Mineralized gold has been intersected in all these four holes. These holes show the Main Zone’s down-dip continuity. The length of the Main zone’s strike is 220 m. This zone remains exposed along the strike towards the down-dip and northern part.
Northern Tiger has drilled two scout holes in the North zone. The company has found visible gold in hole 3ANZ-11-01 and has sent the drill core split sample to the laboratory. The company did not find any significant assay results from the second hole in the North zone. It has also drilled two scout holes at the Road Showing that cuts several narrow and low-grade mineralized gold zones.
Written by
Joel relocated to Australia in 1995 from the United Kingdom and spent five years working in the mining industry as an exploration geotechnician. His role involved utilizing GIS mapping and CAD software. Upon transitioning to the North Coast of NSW, Australia, Joel embarked on a career as a graphic designer at a well-known consultancy firm. Subsequently, he established a successful web services business catering to companies across the eastern seaboard of Australia. It was during this time that he conceived and launched News-Medical.Net. Joel has been an integral part of AZoNetwork since its inception in 2000. Joel possesses a keen interest in exploring the boundaries of technology, comprehending its potential impact on society, and actively engaging with AI-driven solutions and advancements.
Please use one of the following formats to cite this article in your essay, paper or report:
APA
Scanlon, Joel. (2019, February 18). Northern Tiger Resources Obtains Final Assay Results from 3Ace Property. AZoMining. Retrieved on February 08, 2026 from https://www.azomining.com/News.aspx?newsID=5783.
MLA
Scanlon, Joel. "Northern Tiger Resources Obtains Final Assay Results from 3Ace Property". AZoMining. 08 February 2026. <https://www.azomining.com/News.aspx?newsID=5783>.
Chicago
Scanlon, Joel. "Northern Tiger Resources Obtains Final Assay Results from 3Ace Property". AZoMining. https://www.azomining.com/News.aspx?newsID=5783. (accessed February 08, 2026).
Harvard
Scanlon, Joel. 2019. Northern Tiger Resources Obtains Final Assay Results from 3Ace Property. AZoMining, viewed 08 February 2026, https://www.azomining.com/News.aspx?newsID=5783.
We're committed to providing free access to quality science. By registering and providing insight into
your preferences you're joining a community of over 1m science interested individuals and help us to
provide you with insightful content whilst keeping our service free.
or
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.